ROY B et al. TRANSACTIVATION OF THE HUMAN P53 TUMOR-SUPPRESSOR GENE BY C-MYC/MAX CONTRIBUTES TO ELEVATED MUTANT P53 EXPRESSION IN SOME TUMORS. (1994) MOLECULAR AND CELLULAR BIOLOGY 0270-7306 1098-5549 14 12 7805-7815,
1200068
Szakcikk (Folyóiratcikk) | Tudományos[1200068]
Deshpande SD et al. Transforming Growth Factor-beta-Induced Cross Talk Between p53 and a MicroRNA in the Pathogenesis of Diabetic Nephropathy. (2013) DIABETES 0012-1797 1939-327X 62 9 3151-3162
Lajin B et al. Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women. (2013) BREAST CANCER RESEARCH AND TREATMENT 0167-6806 1573-7217 138 2 611-619
Xie YX et al. SirT1 regulates radiosensitivity of hepatoma cells differently under normoxic and hypoxic conditions. (2012) CANCER SCIENCE: THE OFFICIAL JOURNAL OF THE JAPANESE CANCER ASSOCIATION 1347-9032 1349-7006 103 7 1238-1244
Chuang JC et al. Docetaxel and 5-fluorouracil induce human p53 tumor suppressor gene transcription via a short sequence at core promoter element. (2012) TOXICOLOGY IN VITRO 0887-2333 1879-3177 26 5 678-685
Saldana-Meyer R et al. Transcriptional and epigenetic regulation of the p53 tumor suppressor gene. (2011) EPIGENETICS 1559-2294 1559-2308 6 9 1068-1077
Yang HP et al. Switch from Mnt-Max to Myc-Max Induces p53 and Cyclin D1 Expression and Apoptosis During Cholestasis in Mouse and Human Hepatocytes. (2009) HEPATOLOGY 0270-9139 1527-3350 49 3 860-870
Lai JC et al. O(6)-Methylguanine-DNA Methyltransferase Hypermethylation Modulated by 17 beta-Estradiol in Lung Cancer Cells. (2009) ANTICANCER RESEARCH 0250-7005 1791-7530 29 7 2535-2540
Kato M et al. MicroRNAs and Their Role in Progressive Kidney Diseases. (2009) CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 1555-9041 1555-905X 4 7 1255-1266
Yoshiya G et al. Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer. (2008) JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 0815-9319 1440-1746 23 6 948-953
Buyru N et al. p53 genotypes and haplotypes associated with risk of breast cancer. (2007) CANCER DETECTION AND PREVENTION 0361-090X 1877-7821 31 3 207-213
Tan XL et al. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?. (2007) PHARMACOGENETICS AND GENOMICS 1744-6872 1744-6880 17 8 639-645
Shih CM et al. Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance. (2007) CANCER DETECTION AND PREVENTION 0361-090X 1877-7821 31 5 366-370
Kuroda Y et al. Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis. (2007) ORAL ONCOLOGY 1368-8375 1879-0593 43 10 1043-1048
Schneider BG et al. Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation. (2006) EXPERIMENTAL EYE RESEARCH 0014-4835 1096-0007 82 1 91-98
Lai KC et al. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer. (2005) HEPATO-GASTROENTEROLOGY 0172-6390 52 63 944-948
Jones JS et al. p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. (2004) CLINICAL CANCER RESEARCH 1078-0432 1557-3265 10 17 5845-5849
Tong XJ et al. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway. (2004) ONCOGENE 0950-9232 1476-5594 23 28 4847-4855
Chang F et al. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. (2003) LEUKEMIA 0887-6924 1476-5551 17 7 1263-1293
Oster SK et al. The myc oncogene: (M)under-bar-arvelousl(Y)under-bar (C)under-bar-omplex. (2002) ADVANCES IN CANCER RESEARCH 0065-230X 2162-5557 84 81-154
Kahnt K et al. SIV-associated lymphomas in rhesus monkeys (Macaca mulatta) in comparison with HIV-associated lymphomas. (2002) VETERINARY PATHOLOGY 0300-9858 1544-2217 39 1 42-55
Hiyama T et al. p53 codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. (2002) INTERNATIONAL JOURNAL OF CANCER 0020-7136 1097-0215 100 3 304-308
Yu Q et al. Identification of Myc-mediated death response pathways by microarray analysis. (2002) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 277 15 13059-13066
Miller DP et al. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. (2002) CANCER RESEARCH 0008-5472 1538-7445 62 10 2819-2823
Kim BJ et al. Calpeptin suppresses tumor necrosis factor-alpha-induced death and accumulation of p53 in L929 mouse sarcoma cells. (2002) APOPTOSIS 1360-8185 1573-675X 7 2 115-121
Lee SG et al. Transcriptional repression of the human p53 gene by cobalt chloride mimicking hypoxia. (2001) FEBS LETTERS 0014-5793 1873-3468 507 3 259-263
Jain AN et al. Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. (2001) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 0027-8424 1091-6490 98 14 7952-7957
Moudgil VK et al. Hormonal regulation of tumor suppressor proteins in breast cancer cells. (2001) JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 0960-0760 1879-1220 76 1-5 105-117
Rapoport AP et al. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes. (2001) BLOOD CELLS MOLECULES AND DISEASES 1079-9796 1096-0961 27 3 610-624
Adachi S et al. c-Myc is necessary for DNA damage-induced apoptosis in the G(2) phase of the cell cycle. (2001) MOLECULAR AND CELLULAR BIOLOGY 0270-7306 1098-5549 21 15 4929-4937
Lee M et al. Characterization of nuclear factors binding to AT-Rich element in the rat p53 promoter. (2001) JOURNAL OF CELLULAR BIOCHEMISTRY 0730-2312 1097-4644 80 4 580-588
Honda M et al. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. (2000) HEPATOLOGY 0270-9139 1527-3350 31 6 1351-1359
Brunner T et al. Expression of Fas ligand in activated T cells is regulated by c-Myc. (2000) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 275 13 9767-9772
Ceballos E et al. c-Myc antagonizes the effect of p53 on apoptosis and p21(WAF1) transactivation in K562 leukemia cells. (2000) ONCOGENE 0950-9232 1476-5594 19 18 2194-2204
Lee M et al. Characterization of a nuclear factor that binds to AP1-like element in the rat p53 promoter during liver regeneration. (2000) JOURNAL OF CELLULAR BIOCHEMISTRY 0730-2312 1097-4644 80 1 124-132
Lee M et al. Biochemical characterization of a nuclear factor that binds to NF1-like elements in the rat p53 promoter. (2000) JOURNAL OF CELLULAR BIOCHEMISTRY 0730-2312 1097-4644 78 1 1-7
Liu JW et al. The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M. (1999) CELL GROWTH AND DIFFERENTIATION 1044-9523 1541-7786 10 10 677-683
Lee M et al. In vitro transcription assay with the purified 40kDa NF1-like protein binding to the rat p53 promoter.. (1999) BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL 1039-9712 47 3 427-434
Bruckheimer EM et al. Implications of cell death regulation in the pathogenesis and treatment of prostate cancer. (1999) SEMINARS IN ONCOLOGY 0093-7754 1532-8708 26 4 382-398
Kirch HC et al. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappa B and Myc/Max. (1999) ONCOGENE 0950-9232 1476-5594 18 17 2728-2738
Hurd C et al. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells. (1999) ONCOGENE 0950-9232 1476-5594 18 4 1067-1072
Nayak BK et al. Differential binding of NF1 transcription factor to P53 gene promoter and its depletion in human breast tumours. (1999) MOLECULAR BIOLOGY REPORTS 0301-4851 1573-4978 26 4 223-230
Watanabe H et al. Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas. (1999) JAPANESE JOURNAL OF CANCER RESEARCH 0910-5050 90 1 40-47
Lee M et al. Analysis of promoter elements for transcriptional expression of rat p53 gene in regenerating liver. (1999) JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY 1225-8687 0219-1024 1976-670X 32 1 45-50
Lee M et al. A 40-kDa NF1-like protein, not YY1, binds to the rat p53 promoter for transactivation in various rat organs. (1999) BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE 0829-8211 1208-6002 77 3 209-214
Lee MY et al. Transcription of the rat p53 gene is mediated by factor binding to two recognition motifs of NF1-Like protein. (1998) BIOLOGICAL CHEMISTRY 1431-6730 1437-4315 379 11 1333-1340
Lee M et al. Transcription of the rat p53 gene is induced by a 39kDa protein binding to the p53 promoter region during the liver regeneration. (1998) BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL 1039-9712 46 4 765-774
Spiller DG et al. The influence of target protein half-life on the effectiveness of antisense oligonucleotide analog-mediated biologic responses. (1998) ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT 1087-2906 2159-3345 2159-3337 8 4 281-293
Peters MA et al. Target genes and cellular regulators of the Myc transcription complex. (1998) CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION 1045-4403 2162-6502 8 3-4 277-296
Wu M et al. Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21(WAF1/CTP1) in receptor-mediated apoptosis of WEHI 231 B lymphoma cells. (1998) JOURNAL OF EXPERIMENTAL MEDICINE 0022-1007 1540-9538 187 10 1671-1679
Griffioen M et al. Repression of the minimal HLA-B promoter by c-myc and p53 occurs through independent mechanisms. (1998) MOLECULAR IMMUNOLOGY 0161-5890 1872-9142 35 13 829-835
Walker CW et al. New perspectives on sea urchin gametogenesis and their relevance to aquaculture. (1998) JOURNAL OF SHELLFISH RESEARCH 0730-8000 1943-6319 17 5 1507-1514
Zindy F et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. (1998) GENES & DEVELOPMENT 0890-9369 1549-5477 12 15 2424-2433
Giorello L et al. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix l-type peptide fused to an internalization sequence. (1998) CANCER RESEARCH 0008-5472 1538-7445 58 16 3654-3659
Sommer A et al. Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators. (1998) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 273 12 6632-6642
Martin A et al. Functional analysis of the p53 protein in AIDS-related non-Hodgkin's lymphomas and polymorphic lymphoproliferations. (1998) BRITISH JOURNAL OF HAEMATOLOGY 0007-1048 1365-2141 101 2 311-317
Bateman E. Autoregulation of eukaryotic transcription factors. (1998) PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY 0079-6603 1877-1173 2211-9108 60 133-168
Ray RB et al. Transcriptional repression of p53 promoter by hepatitis C virus core protein. (1997) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 272 17 10983-10986
Mansukhani MM et al. The pattern of p53 and p21(WAF1/CIP1) immunoreactivity in non-Hodgkin's lymphomas predicts p53 gene status. (1997) DIAGNOSTIC MOLECULAR PATHOLOGY 1052-9551 1533-4066 6 4 222-228
Dang CV et al. Role of oncogenic transcription factor c-Myc in cell cycle regulation, apoptosis and metabolism. (1997) JOURNAL OF BIOMEDICAL SCIENCE 1021-7770 1423-0127 4 6 269-278
Yu K et al. Regulation of myc-dependent apoptosis by p53, c-Jun N-terminal kinases stress-activated protein kinases, and Mdm-2. (1997) CELL GROWTH AND DIFFERENTIATION 1044-9523 1541-7786 8 7 731-742
Boyd KE et al. Myc versus USF: Discrimination at the cad gene is determined by core promoter elements. (1997) MOLECULAR AND CELLULAR BIOLOGY 0270-7306 1098-5549 17 5 2529-2537
Lee TC et al. Myc represses transcription of the growth arrest gene gas1. (1997) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 0027-8424 1091-6490 94 24 12886-12891
Lallemand C et al. Identification of a novel transcriptional regulatory element common to the p53 and interferon regulatory factor 1 genes. (1997) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 272 47 29801-29809
Campomenosi P et al. Heterogeneous p53 mutations in a Burkitt lymphoma from an AIDS patients with monoclonal c-myc and VDJ rearrangements. (1997) INTERNATIONAL JOURNAL OF CANCER 0020-7136 1097-0215 73 6 816-821
Liu P et al. Hepatocarcinogenesis in woodchuck hepatitis virus e-myc mice: Sustained cell proliferation and biphasic activation of insulin-like growth factor II. (1997) HEPATOLOGY 0270-9139 1527-3350 25 4 874-883
Nayak BK et al. Differential binding of nuclear proteins to the TP53 gene promoter in male breast tumour. (1997) EUROPEAN JOURNAL OF CANCER 0959-8049 1879-2995 1879-0852 0014-2964 33 9 1484-1487
Kel' OV et al. Complex gene network in cell cycle regulation: Central role of the E2F family of transcription factors. (1997) MOLECULAR BIOLOGY 0026-8933 1608-3245 31 4 548-561
Janson W et al. Butyrate modulates DNA-damage-induced p53 response by induction of p53-independent differentiation and apoptosis. (1997) ONCOGENE 0950-9232 1476-5594 15 12 1395-1406
Lee M et al. A 100 kDa protein binding to bHLH family consensus recognition sequence of RAT p53 promoter. (1997) JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY 1225-8687 0219-1024 1976-670X 30 3 205-210
Furlong EEM et al. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity. (1996) MOLECULAR AND CELLULAR BIOLOGY 0270-7306 1098-5549 16 10 5933-5945
Kukushkin AN et al. Transcription factors C/EBP and AP-1 modulate promoter activity of human p53 regulatory region. (1996) MOLECULAR BIOLOGY 0026-8933 1608-3245 30 1 56-62
Shounan Y et al. Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis. (1996) LEUKEMIA 0887-6924 1476-5551 10 10 1619-1628
Henriksson M et al. Proteins of the Myc network: Essential regulators of cell growth and differentiation. (1996) ADVANCES IN CANCER RESEARCH 0065-230X 2162-5557 68 109-182
Abshire MK et al. In vitro exposure to cadmium in rat L6 myoblasts can result in both enhancement and suppression of malignant progression in vivo. (1996) CARCINOGENESIS 0143-3334 1460-2180 17 6 1349-1356
Lemaitre JM et al. c-Myc in the control of cell proliferation and embryonic development. (1996) ADVANCES IN CANCER RESEARCH 0065-230X 2162-5557 70 95-144
Lee LA et al. A link between c-myc-mediated transcriptional repression and neoplastic transformation. (1996) JOURNAL OF CLINICAL INVESTIGATION 0021-9738 1558-8238 97 7 1687-1695
LEE JH et al. INDUCTION OF P53 AND APOPTOSIS BY DELTA(12)-PGJ(2) IN HUMAN HEPATOCARCINOMA SK-HEP-1 CELLS. (1995) FEBS LETTERS 0014-5793 1873-3468 368 2 348-352
